<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font25 { font-size : 25; }</style>
 <body>
  <p>
   <span class="font32">omega- </span>
   <span class="font25">patients </span>
   <span class="font24">effects </span>
   <span class="font24">isotretinoin </span>
   <span class="font23">acne </span>
   <span class="font23">{border-style </span>
   <span class="font22">group </span>
   <span class="font22">px;} </span>
   <span class="font21">#ffffff;} </span>
   <span class="font20">oral </span>
   <span class="font20"> Week </span>
   <span class="font19">fatty </span>
   <span class="font17">acids </span>
   <span class="font16">severe </span>
   <span class="font16">study </span>
   <span class="font16">Isotretinoin </span>
   <span class="font16">mucocutaneous </span>
   <span class="font15">(%) </span>
   <span class="font15">case </span>
   <span class="font15">dry </span>
   <span class="font15">dryness </span>
   <span class="font15">px; </span>
   <span class="font15">receiving </span>
   <span class="font15">skin </span>
   <span class="font15">weeks </span>
   <span class="font15">{font-family </span>
   <span class="font14">Acne </span>
   <span class="font14">Dry </span>
   <span class="font14">Omega- </span>
   <span class="font14">eye </span>
   <span class="font14">font-size </span>
   <span class="font14">treatment </span>
   <span class="font14">vulgaris </span>
   <span class="font14">acid </span>
   <span class="font14">administration </span>
   <span class="font14">article </span>
   <span class="font14">common </span>
   <span class="font14">control </span>
   <span class="font14">double; </span>
   <span class="font14">frequent </span>
   <span class="font14">groups </span>
   <span class="font14">review </span>
   <span class="font14">role </span>
   <span class="font14">symptoms </span>
   <span class="font14">treated </span>
   <span class="font13">Dermatology </span>
   <span class="font13">border-color </span>
   <span class="font13">border-width </span>
   <span class="font13">isotretinoin. </span>
   <span class="font13">solid; </span>
   <span class="font13">studies </span>
   <span class="font13">{font-style </span>
   <span class="font13">{font-weight </span>
   <span class="font12">Patients </span>
   <span class="font12">Research </span>
   <span class="font12">Table </span>
   <span class="font12">adverse </span>
   <span class="font12">bold </span>
   <span class="font12">courier; </span>
   <span class="font12">did </span>
   <span class="font12">em; </span>
   <span class="font12">eyes </span>
   <span class="font12">groups. </span>
   <span class="font12">isotretinoin, </span>
   <span class="font12">lesions </span>
   <span class="font12">levels </span>
   <span class="font12">no. </span>
   <span class="font12">nose </span>
   <span class="font12">polyunsaturated </span>
   <span class="font12">pt;} </span>
   <span class="font12">received </span>
   <span class="font12">recent </span>
   <span class="font12">reduced </span>
   <span class="font12">significantly </span>
   <span class="font12">therapy </span>
   <span class="font12">using </span>
   <span class="font12"> Baseline </span>
  </p>
 </body>
</html>
